Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$11.84 +3.9%	$12.29	$11.21 ▼ $25.36	$547.30M	1.12	393,933 shs	604,719 shs
BFLY Butterfly Network	$1.90 +0.8%	$2.17	$0.90 ▼ $4.98	$468.62M	2.46	3.25 million shs	2.49 million shs
BWAY Brainsway	$12.10 +0.1%	$11.46	$5.98 ▼ $13.66	$228.65M	1.4	69,185 shs	21,462 shs
RXST RxSight	$7.26 -1.2%	$13.32	$6.32 ▼ $58.23	$295.05M	1.21	823,013 shs	1.35 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	+1.33%	-3.83%	-6.13%	-7.10%	-48.16%
BFLY Butterfly Network	+0.80%	+3.29%	-9.16%	-20.46%	+76.17%
BWAY Brainsway	0.00%	-1.14%	+10.82%	+44.96%	+86.00%
RXST RxSight	0.00%	-5.04%	-46.00%	-48.67%	-84.28%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS Avanos Medical	3.1911 of 5 stars	0.0	5.0	2.6	1.7	2.5
BFLY Butterfly Network	2.5743 of 5 stars	3.5	1.0	2.9	2.5	0.6
BWAY Brainsway	2.5038 of 5 stars	2.5	4.0	0.0	0.8	1.9
RXST RxSight	2.5437 of 5 stars	4.0	1.0	2.2	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	0.00	N/A	N/A	N/A
BFLY Butterfly Network	3.00	Buy	$3.50	84.70% Upside
BWAY Brainsway	3.00	Buy	$14.25	17.77% Upside
RXST RxSight	1.91	Reduce	$17.50	141.05% Upside

Current Analyst Ratings Breakdown

Latest BWAY, BFLY, RXST, and AVNS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	RXST RxSight	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$20.00 ➝ $9.00
7/10/2025	RXST RxSight	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$24.00 ➝ $9.00
7/9/2025	RXST RxSight	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform ➝ Underperform	$18.00 ➝ $9.00
7/9/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$18.00 ➝ $10.00
7/9/2025	RXST RxSight	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$17.00 ➝ $9.00
7/9/2025	RXST RxSight	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/9/2025	RXST RxSight	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$25.00 ➝ $9.00
7/9/2025	RXST RxSight	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00
7/9/2025	RXST RxSight	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
7/1/2025	BFLY Butterfly Network	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$3.00
6/9/2025	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00

(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$689.20M	0.79	$12.46 per share	0.95	$18.03 per share	0.66
BFLY Butterfly Network	$82.06M	5.71	N/A	N/A	$0.79 per share	2.40
BWAY Brainsway	$43.46M	5.26	$0.25 per share	48.48	$3.31 per share	3.66
RXST RxSight	$139.93M	2.11	N/A	N/A	$6.98 per share	1.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$392.10M	-$8.37	N/A	6.84	N/A	-55.80%	6.26%	4.63%	7/30/2025 (Estimated)
BFLY Butterfly Network	-$72.49M	-$0.29	N/A	N/A	N/A	-75.56%	-29.97%	-21.13%	8/1/2025 (Confirmed)
BWAY Brainsway	$2.92M	$0.20	60.50	75.63	N/A	9.01%	7.35%	4.72%	8/5/2025 (Estimated)
RXST RxSight	-$27.45M	-$0.67	N/A	N/A	N/A	-17.90%	-9.54%	-8.51%	8/7/2025 (Estimated)

Latest BWAY, BFLY, RXST, and AVNS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Guidance Update	RXST RxSight	-$0.0363	N/A	N/A	N/A	$39.78 million	N/A
8/5/2025	Q2 2025	BWAY Brainsway	$0.07	N/A	N/A	N/A	$12.34 million	N/A
8/1/2025	Q2 2025	BFLY Butterfly Network	-$0.07	N/A	N/A	N/A	$23.91 million	N/A
7/30/2025	Q2 2025	AVNS Avanos Medical	$0.18	N/A	N/A	N/A	$165.50 million	N/A
5/13/2025	Q1 2025	BWAY Brainsway	$0.02	$0.04	+$0.02	$0.04	$11.45 million	$11.54 million
5/7/2025	Q1 2025	RXST RxSight	-$0.03	-$0.03	N/A	-$0.20	$38.74 million	$37.90 million
5/6/2025	Q1 2025	AVNS Avanos Medical	$0.19	$0.26	+$0.07	$0.14	$161.75 million	$167.50 million
5/2/2025	Q1 2025	BFLY Butterfly Network	-$0.09	-$0.06	+$0.03	-$0.06	$21.16 million	$21.23 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
BWAY Brainsway	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.12	2.57	1.56
BFLY Butterfly Network	N/A	6.06	4.43
BWAY Brainsway	N/A	5.03	4.75
RXST RxSight	N/A	12.68	11.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
BFLY Butterfly Network	37.85%
BWAY Brainsway	30.11%
RXST RxSight	78.78%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.64%
BFLY Butterfly Network	25.18%
BWAY Brainsway	19.00%
RXST RxSight	9.57%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	2,227	46.24 million	45.02 million	Optionable
BFLY Butterfly Network	460	247.29 million	185.02 million	Optionable
BWAY Brainsway	120	18.90 million	15.31 million	Not Optionable
RXST RxSight	220	40.64 million	36.75 million	Optionable

BWAY, BFLY, RXST, and AVNS Headlines

Recent News About These Companies

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

July 22 at 10:00 AM | prnewswire.com

RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: RXST)? You may have been Affected by Fraud and are Urged to Contact BFA Law

July 22 at 8:47 AM | globenewswire.com

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST

July 21 at 1:09 PM | businesswire.com

RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm

July 21 at 10:21 AM | prnewswire.com

RXST SECURITIES NEWS: Did RxSight, Inc. (NASDAQ:RXST) Commit Securities Fraud? Contact BFA Law ...

July 20 at 8:26 AM | gurufocus.com

RXST SECURITIES NEWS: Did RxSight, Inc. (NASDAQ:RXST) Commit Securities Fraud? Contact BFA Law about its Investigation into the Company

July 20 at 7:08 AM | globenewswire.com

What Does The Future Hold For RxSight, Inc. (NASDAQ:RXST)? These Analysts Have Been Cutting Their Estimates

July 19 at 8:38 PM | finance.yahoo.com

New York State Common Retirement Fund Has $10.28 Million Stock Position in RxSight, Inc. (NASDAQ:RXST)

July 19 at 4:22 AM | marketbeat.com

RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm

July 18, 2025 | gurufocus.com

RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm

July 18, 2025 | tmcnet.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. ...

July 18, 2025 | gurufocus.com

RXST INVESTIGATION: RxSight, Inc. (NASDAQ:RXST) 38% Stock Drop Triggers Securities Fraud ...

July 18, 2025 | gurufocus.com

RXST INVESTIGATION: RxSight, Inc. (NASDAQ:RXST) 38% Stock Drop Triggers Securities Fraud Investigation – Contact BFA Law if You Lost Money

July 18, 2025 | globenewswire.com

RXST BREAKING NEWS: BFA Law is Investigating RxSight, Inc. for Securities Fraud; Contact the Firm about how to Potentially Recover Investment Losses

July 17, 2025 | businesswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

July 17, 2025 | prnewswire.com

RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 16, 2025 | businesswire.com

Morgan Stanley Downgrades RxSight (RXST)

July 16, 2025 | msn.com

RXSIGHT ALERT: Bragar Eagel & Squire, P.C.Announces Investigation into RxSight, Inc. (RXST) and Encourages Investors to Contact the Firm

July 15, 2025 | globenewswire.com

Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders

July 15, 2025 | globenewswire.com

Securities Fraud Investigation Into RxSight, Inc. (RXST) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

July 15, 2025 | businesswire.com

Morgan Stanley Downgrades RxSight (NASDAQ:RXST) to Equal Weight

July 15, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BWAY, BFLY, RXST, and AVNS Company Descriptions

Avanos Medical NYSE:AVNS

$11.84 +0.45 (+3.91%)

Closing price 03:58 PM Eastern

Extended Trading

$11.84 +0.01 (+0.08%)

As of 04:10 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Butterfly Network NYSE:BFLY

$1.90 +0.02 (+0.80%)

Closing price 03:58 PM Eastern

Extended Trading

$1.90 +0.01 (+0.53%)

As of 07:08 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Brainsway NASDAQ:BWAY

$12.10 +0.01 (+0.08%)

Closing price 04:00 PM Eastern

Extended Trading

$12.22 +0.12 (+0.99%)

As of 05:40 PM Eastern

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

RxSight NASDAQ:RXST

$7.26 -0.09 (-1.22%)

Closing price 04:00 PM Eastern

Extended Trading

$7.26 0.00 (-0.01%)

As of 07:06 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time